HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Rockefeller Capital Management L.P.

Rockefeller Capital Management L.P. trimmed its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 28.3% in the second quarter, Holdings Channel.com reports. The institutional investor owned 30,328 shares of the company’s stock after selling 11,995 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in HealthEquity were worth $2,440,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the company. SG Capital Management LLC acquired a new stake in shares of HealthEquity in the second quarter valued at about $7,363,000. Stephens Investment Management Group LLC raised its position in shares of HealthEquity by 34.2% in the second quarter. Stephens Investment Management Group LLC now owns 695,769 shares of the company’s stock valued at $55,995,000 after buying an additional 177,467 shares during the last quarter. O Shaughnessy Asset Management LLC raised its position in shares of HealthEquity by 5.3% in the second quarter. O Shaughnessy Asset Management LLC now owns 5,932 shares of the company’s stock valued at $477,000 after buying an additional 296 shares during the last quarter. HighTower Advisors LLC increased its position in HealthEquity by 0.7% during the second quarter. HighTower Advisors LLC now owns 83,940 shares of the company’s stock worth $6,758,000 after purchasing an additional 543 shares during the last quarter. Finally, Sei Investments Co. increased its position in HealthEquity by 2.4% during the second quarter. Sei Investments Co. now owns 846,664 shares of the company’s stock worth $68,126,000 after purchasing an additional 19,596 shares during the last quarter.

In other news, VP William Robert Otten sold 1,850 shares of the firm’s stock in a transaction that occurred on Monday, August 2nd. The shares were sold at an average price of $74.47, for a total value of $137,769.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Darcy G. Mott sold 6,000 shares of the firm’s stock in a transaction that occurred on Monday, June 21st. The shares were sold at an average price of $77.18, for a total transaction of $463,080.00. Following the completion of the transaction, the insider now directly owns 85,052 shares of the company’s stock, valued at approximately $6,564,313.36. The disclosure for this sale can be found here. In the last three months, insiders sold 41,635 shares of company stock valued at $3,121,958. Insiders own 2.80% of the company’s stock.

Shares of HQY opened at $64.06 on Friday. HealthEquity, Inc. has a 1-year low of $45.82 and a 1-year high of $93.32. The stock has a market cap of $5.35 billion, a PE ratio of 6,406.00, a P/E/G ratio of 5.22 and a beta of 1.37. The firm has a 50-day simple moving average of $68.92 and a two-hundred day simple moving average of $73.49. The company has a debt-to-equity ratio of 0.48, a current ratio of 4.65 and a quick ratio of 4.50.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, September 7th. The company reported $0.40 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.04. HealthEquity had a net margin of 0.10% and a return on equity of 5.25%. The business had revenue of $189.10 million during the quarter, compared to analysts’ expectations of $184.99 million. During the same period last year, the business earned $0.29 earnings per share. The business’s revenue for the quarter was up 7.4% on a year-over-year basis. As a group, sell-side analysts expect that HealthEquity, Inc. will post 0.95 earnings per share for the current fiscal year.

Several equities research analysts recently issued reports on HQY shares. Barrington Research restated a “buy” rating and set a $90.00 price objective on shares of HealthEquity in a research report on Thursday, September 9th. Robert W. Baird restated a “hold” rating and set a $86.00 price objective on shares of HealthEquity in a research report on Monday, May 24th. Stephens started coverage on shares of HealthEquity in a research report on Thursday, July 1st. They set an “overweight” rating and a $100.00 price objective for the company. Cantor Fitzgerald raised their price objective on shares of HealthEquity from $82.00 to $85.00 and gave the stock an “overweight” rating in a research report on Tuesday, June 8th. Finally, BTIG Research restated a “hold” rating on shares of HealthEquity in a research report on Tuesday, June 8th. Three equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Buy” and an average target price of $87.40.

HealthEquity Company Profile

HealthEquity, Inc provides range of solutions for managing health care accounts. The firm’s offers its solutions for employers, health plans, brokers, consultants and financial advisors. Its services include HAS, FSA, HRA, DCRA, 401(k), Commuter, COBRA and HIA. It also offers products like healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives.

Read More: How are institutional investors different from individual investors?

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.